Home Ingredients Hesperidin
Cardiovascular

Hesperidin

Evidence Level
Strong
2 Clinical Trials
5 Documented Benefits
4/5 Evidence Score

Hesperidin is a flavanone glycoside found primarily in citrus fruits — particularly oranges, grapefruits, and lemons (highest concentration in peel and pith). Studied for vascular health, chronic venous insufficiency, hemorrhoids, and capillary fragility. Used widely in Europe (combined with diosmin as Daflon®/Detralex®) for venous diseases. Strong evidence for venous and microcirculation support.

Studied Dose 500-1,000 mg/day general; 450-900 mg/day combined with diosmin for venous insufficiency (Daflon® 500 mg = 450 mg diosmin + 50 mg hesperidin)
Active Compound Hesperidin (4'-methoxy-7-O-rutinosyl-naringenin)

Benefits

Chronic Venous Insufficiency Treatment

Hesperidin combined with diosmin (Daflon®/Detralex®) is established prescription medication in Europe for chronic venous insufficiency (varicose veins, leg edema, leg pain). Multiple meta-analyses and the RELIEF Study confirm efficacy. Substantial evidence base.

Supported by Trial 1

Hemorrhoid Treatment

Hesperidin/diosmin is first-line nonsurgical treatment for hemorrhoidal disease in many European guidelines. Reduces bleeding, pain, swelling. Comparable efficacy to many topical/surgical interventions for grade I-II hemorrhoids.

Supported by Trial 2

Microcirculation / Capillary Fragility

Reduces capillary fragility and improves microcirculation — relevant for diabetes, retinopathy, easy bruising, lymphedema. Long-established 'venotonic' agent.

Supported by Trial 2

Anti-Inflammatory / Antioxidant

Reduces inflammatory markers, oxidative stress, endothelial dysfunction — broad cardiovascular protective effects beyond just venous applications.

Supported by Trial 1, Trial 2

Modest Cardiovascular Risk Marker Effects

Some trials show modest improvements in blood pressure, lipids, endothelial function. Effect smaller than dedicated cardiovascular medications. General CV support component.

Mechanism of action

1

Venotonic / Vasoconstrictor Activity

Hesperidin (and diosmin) increase venous tone and reduce venous distensibility — basis for venous insufficiency treatment. Improves valve function and reduces venous reflux.

2

Lymphatic Drainage Enhancement

Increases lymphatic contractility — improves lymph drainage. Relevant for edema, lymphedema, lymphatic stagnation.

3

Anti-Inflammatory / Adhesion Molecule Reduction

Reduces leukocyte adhesion to endothelium, decreases inflammatory cytokines. Limits the inflammatory cascade that contributes to chronic venous disease.

4

Capillary Permeability Reduction

Decreases capillary permeability — reduces fluid leakage, improves capillary integrity. Foundational mechanism for 'capillary fragility' applications.

Clinical trials

1
Hesperidin/Diosmin for CVI — RELIEF Study

Large prospective international study of micronized purified flavonoid fraction (90% diosmin + 10% hesperidin) in 5,052 patients with chronic venous insufficiency for 6 months.

5,052 CVI patients (international).

Significant improvement in CVI symptoms (edema, pain, leg heaviness, cramps), quality of life. Foundational evidence supporting MPFF as venous insufficiency treatment. Multiple subsequent pooled analyses confirmed efficacy.

2
Hesperidin/Diosmin for Hemorrhoids — Evidence Synthesis

Pooled analyses and evidence reviews of MPFF (diosmin/hesperidin) for hemorrhoidal disease.

Pooled across hemorrhoid clinical trials.

MPFF significantly reduces hemorrhoid bleeding, pain, swelling. Recommended in European guidelines. Reasonable first-line nonsurgical option.

Side effects and drug interactions

Common Potential side effects

Generally very well-tolerated.
Mild GI distress (nausea, abdominal pain, diarrhea).
Headache.
Skin reactions / contact dermatitis rare.
Allergic reactions to citrus rare.
Hot flushes (rare).

Important Drug interactions

Generally minimal drug interactions.
Anticoagulants — minimal effect; theoretical at very high doses.
Calcium channel blockers — theoretical interaction (citrus flavonoids modify CYP3A4); clinically minor.
Pregnancy/lactation — limited safety data for supplementation; avoid; dietary citrus safe.

Featured in these supplement guides

Circulation & Varicose Veins→

More Cardiovascular Ingredients

Cardiovascular
Niacin
Niacin (vitamin B3) is an essential water-soluble vitamin central to energy metabolism, DN…
Cardiovascular
Omega-3 Fatty Acids
Omega-3 fatty acids, primarily eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), an…
Cardiovascular
Potassium
Potassium is the most abundant intracellular cation in the human body and an essential min…
Cardiovascular
Pycnogenol® (French Maritime Pine Bark)
Pycnogenol® (Horphag Research) is a standardized extract from the bark of French maritime…

Explore Other Ingredients

Cognitive
Rhodiola Rosea
Rhodiola rosea is an adaptogenic herb traditionally used in cold northern regions to comba…
Cognitive
Suntheanine®
Suntheanine® is a patented, 100% pure L-isomer theanine produced via an enzymatic process…
Cognitive
Ashwagandha
Ashwagandha (Withania somnifera) is an adaptogenic herb from Ayurvedic tradition, widely u…

Frequently asked questions about Hesperidin

What is hesperidin used for?

Hesperidin is a flavonoid found in citrus peels (especially oranges). It is studied for supporting blood-vessel and vein health, healthy circulation and blood pressure, and antioxidant activity. It is often combined with diosmin for vein support.

Does hesperidin help with veins or circulation?

Hesperidin, especially with diosmin, is used to support vein tone and healthy circulation, including for tired, heavy legs and hemorrhoid comfort. Its effects on the blood vessels underlie these uses.

How much hesperidin should I take?

Vein-support products often provide hesperidin combined with diosmin (for example 50 mg hesperidin with 450 mg diosmin). For other uses, follow product labeling, commonly a few hundred milligrams per day.

Is hesperidin safe?

Hesperidin is generally well tolerated, with citrus being a natural source. It may mildly affect blood pressure and interact with some medications, so check with your doctor if you take blood-pressure or blood-thinning drugs.

What is Hesperidin?

Hesperidin is a flavanone glycoside found primarily in citrus fruits — particularly oranges, grapefruits, and lemons (highest concentration in peel and pith). Studied for vascular health, chronic venous insufficiency, hemorrhoids, and capillary fragility.

What is the recommended dosage of Hesperidin?

The clinically studied dose is 500-1,000 mg/day general; 450-900 mg/day combined with diosmin for venous insufficiency (Daflon® 500 mg = 450 mg diosmin + 50 mg hesperidin) Always follow the product label and check with a healthcare provider for personal advice.

Is Hesperidin safe, and does it have side effects?

For most healthy adults, Hesperidin is well tolerated at studied doses. Reported effects can include: Generally very well-tolerated. Mild GI distress (nausea, abdominal pain, diarrhea). It may also interact with some medications. Hesperidin is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Hesperidin interact with any medications?

Possible interactions include: Generally minimal drug interactions. Anticoagulants — minimal effect; theoretical at very high doses. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Hesperidin?

NutraSmarts rates the evidence for Hesperidin as Strong (4 out of 5). It is backed by 2 clinical trials and 4 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(4 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Morand C, Dubray C, Milenkovic D, Lioger D, Martin JF, Scalbert A, et al. Hesperidin contributes to the vascular protective effects of orange juice: a randomized crossover study in healthy volunteers. The American Journal of Clinical Nutrition. 2011;93(1):73-80. doi: 10.3945/ajcn.110.004945.PubMedUsed to support: Backs the venous/endothelial-tone and microcirculation signal: isolated hesperidin (vs control drink) improved diastolic blood pressure and microvascular endothelial reactivity in a crossover RCT. Real but limited evidence — single acute crossover in healthy volunteers using orange-juice-matched dosing.
  2. Milenkovic D, Deval C, Dubray C, Mazur A, Morand C Hesperidin displays relevant role in the nutrigenomic effect of orange juice on blood leukocytes in human volunteers: a randomized controlled cross-over study. PLoS One. 2011;6(11):e26669. doi: 10.1371/journal.pone.0026669.PubMedUsed to support: Mechanistic support for the vascular/endothelial claim: isolated hesperidin drove much of the gene-expression (nutrigenomic) shift in leukocytes toward an anti-atherogenic profile. Small crossover study — supports plausibility of the endothelial signal rather than a hard clinical outcome.
  3. Salden BN, Troost FJ, de Groot E, Stevens YR, Garces-Rimon M, Possemiers S, et al. Randomized clinical trial on the efficacy of hesperidin 2S on validated cardiovascular biomarkers in healthy overweight individuals. The American Journal of Clinical Nutrition. 2016;104(6):1523-1533. doi: 10.3945/ajcn.116.136960.PubMedUsed to support: Backs the endothelial-function signal with honest limits: 6-week isolated hesperidin-2S improved endothelial function (flow-mediated dilation) in overweight adults but did not significantly change most other cardiovascular biomarkers or blood pressure — a real but modest, biomarker-level effect.
  4. Martinez-Zapata MJ, Vernooij RW, Uriona Tuma SM, Stein AT, Moreno RM, Vargas E, et al. Phlebotonics for venous insufficiency. Cochrane Database of Systematic Reviews. 2016;4(4):CD003229. doi: 10.1002/14651858.CD003229.pub3.PubMedUsed to support: Backs the chronic-venous-insufficiency use, honestly framed: this Cochrane review found phlebotonics (including diosmin+hesperidin/flavonoids) probably reduce edema and some CVI symptoms, but evidence quality is low-to-moderate and isolated-hesperidin data are limited because most trials use combination products.